Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.36
-0.68%
Mkt Cap $665.92M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$6.68
Range $1.00 – $18.00
Implied Upside
+53.2%
Consensus $6.68 vs current $4.36